Clinical Trial Update: ENX-104 MAD Study for Participants With Major Depressive Disorder With Anhedonia (aMDD) [Phase 1]

View source ↗

Summary

The document reports the completion of a Phase 1 MAD study of ENX-104 in adults with major depressive disorder with anhedonia (aMDD), sponsored by Engrail Thera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ENX-104

Snippet

Sponsor: Engrail Therapeutics INC | Conditions: Major Depressive Disorder | Phase 1 | Status: COMPLETED